OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 12/30/2022
Week ended 12/30/2022
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 12/30/2022
The Only M&A Deal of the Week:
- On December 27, 2022, Flora Growth Corp. (FLGC: Nasdaq), a leading all-outdoor cultivator, manufacturer, and distributor of global cannabis products, announced the closing of its acquisition of all outstanding shares of Franchise Global Health (FGH: TSX), a multinational operator in medical cannabis with principal operations in Germany.
- The $11.0M consideration was paid through the issuance of 43.5M common shares of Flora.
- The consideration represents a .25x multiple of FGH’s annualized 9-month revenues.
- The deal establishes a foothold for the distribution of wholesale cannabis products in Europe.
- FGH, through a subsidiary, holds the first German medical cannabis import and distribution license, granted in 2017.
Week ended 12/30/2022
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.